These results indicated that enhanced cytotoxic response by co-treatment with nobiletin and PTX in ABCB1 overexpression MDR cancer cells was associated with inhibition of PI3K/AKT and MAP kinase/ERK pathways. The gene discussed is AKT1; the disease is cancer.